Journals By Industry - Nonsteroidal Anti-Inflammatory Drugs

DULUTH, Ga. -- PRIUM's Qualified Medical Intervention (QMI) services received a Business Insurance Innovation Award, which recognizes products and services for professional risk managers that address risk identification, assessment/analysis, control and/or financing. QMI...

COLORADO SPRINGS, Colo. -- Cannabis Science, Inc. (OTCBB: CBIS.OB - News), a pioneering US biotech company developing pharmaceutical cannabis products, is happy to report an additional, apparently successful, self-medicated cannabis treatment for a...

ROCHESTER, Minn. -- Here are highlights from the January issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic...

Let's talk about print. I know everyone is focused on digital, but since you're reading this magazine, I think it's relevant. It's also top of mind for me because this year I headed...

Seven years after the biggest drug safety scandal since thalidomide was found to cause birth defects, Merck and the Justice Department announced a nearly $1 billion settlement of litigation over Vioxx, the Cox-2...

Arthritis and DTC were made for each other, from the golden days of Celebrex to the overcrowded category it is today. Chief among the reasons for this: Chronic pain is highly symptomatic and...

Strengths One of two local pharmaceutical players. Active in supplying both the public and private markets in the country. Some R&D activities. Return to profitability in 2009 after suffering a loss in 2008....

Leading Multinationals Strengths...

Strengths...

Strengths Sizeable product portfolio. Contract manufacturing for foreign players. Operating under the umbrella of the state-controlled pharmaceutical company. Weaknesses Falling sales to non-Arab countries. Sizeable counterfeit activity in the country. Stringent drug registration...

EXTON, Penn. -- According to findings in the ChartTrends([R]): Lupus U.S. 2011 report, only 37% of surveyed rheumatologists feel that their moderate-to-severe SLE patients are optimally managed, indicating that the unmet need in...

Transactions Will Be The Largest in the Company's History IRVINGTON, N.Y. -- Prestige Brands Holdings, Inc. (NYSE-PBH) today announced the signing of a definitive agreements with GSK to acquire 17 over-the-counter (OTC) pharmaceutical...

ALAMEDA, Calif. -- InSite Vision Incorporated (OTCBB:INSV) today announced that Tim McInerney has been elected Chairman of its Board of Directors. Mr. McInerney has served as a member of the Board of Directors...

Russia may reduce import duties on drugs after accession to WTO A document on Russia's obligations regarding the access of goods to the Russian market after its accession to the WTO obtained by...

94 Percent of Pediatricians Say Parents Need More Education on Fever Management MADISON, N.J. -- Tis' the season for sneezing, coughing and fevers. As the temperature drops and cold and flu season gets...

EXTON, Pa. -- The LaunchTrends([R]): Benlysta Wave 3 report, which measures product uptake and commercial effectiveness at six months post launch, finds that over half of surveyed rheumatologists have initiated trial on Benlysta,...

DANVERS, Mass. -- BioChemics, a specialty pharmaceutical company, announced today that it has successfully completed a 14-day Phase 2 study in Switzerland demonstrating the efficacy of BioChemics' transdermal ibuprofen-VALE[R] cream, BC-IBU-CH-001, for the...

Not had time to read the journals? Let Dr Gwen Lewis bring you up to date with the latest research. Stroke risk and NSAID use - Med J Aust 2011: 195 (9): 525-9...

Between 2010 and 2020 the Overall Market for Chronic Pain Therapies Will Remain Stable at Approximately $20 Billion, According to Findings from Decision Resources BURLINGTON, Mass. -- Decision Resources, one of the world's...